All In Biotech

Drug Trial Radar · NCT00262054

Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)

Prospective, Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Bivalirudin and Un-fractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions. ISAR-REACT-3

Last checked: Nov 20, 2026Latest source record: Mar 15, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 4,570 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,570

Actual

Start

Nov 2005

Primary completion

Feb 2008

Study completion May 2008

Sponsor

Lead sponsor
Deutsches Herzzentrum MuenchenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 6, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether bivalirudin given during PCI is associated with better outcomes compared to un-fractionated heparin.

Conditions

  • Coronary Disease
  • Angina Pectoris

Interventions

  • BivalirudinDrug

    bivalirudin to be administered as an intravenous bolus of 0.75 mg/kg prior to the start of the intervention, followed by infusion of 1.75 mg/kg per hour for the duration of the procedure.

  • Un-fractionated heparinDrug

    UFH is given as an intravenous bolus of 140 units/kg followed by infusion of placebo 1.75 mg/kg per hour for the duration of the procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite rate of death, myocardial infarction (MI),urgent target vessel revascularization (TVR) within 30 days or in-hospital major bleedingTime frame: 30 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Herz-Zentrum

    Bad Krozingen, Germany

  • Segeberger Kliniken

    Bad Segeberg, Germany

  • Deutsches Herzzentrum Muenchen

    Munich, Germany

  • First Medizinische Klinik, Klinikum rechts der Isar

    Munich, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.